The relationship stayed significant in multivariate-adjusted analyses except for participants with hepatic steatosis in the lowest AST deciles (AST with NAFLD: hazard ratio (HR) = 1.09, 95% confidence interval (CI) = 0.91–1.31; AST without NAFLD: HR = 1.23, 95% CI = 1.08–1.41; ALT with NAFLD: HR = 1.44, 95% CI = 1.17–1.78; ALT without NAFLD: HR = 1.24, 95% CI = 1.11–1.39) (Figure 1). This evidence concerns the gene GPT and fatty liver disease.